Ace Therapeutics announces its preclinical ophthalmic drug development services to help expedite the discovery of ...
A multinational research team led by Professor Tong Zhang from the Department of Civil Engineering, Faculty of Engineering at ...
Bicuspid aortic valve (BAV) is a common congenital heart defect where the aortic valve has two leaflets (cusps) instead of the usual three, resulting in abnormal blood flow and development of aortic ...
FDA RMAT boosts inhaled gene therapy KB707, delivering IL‑2/IL‑12 to lung tumors; early trial shows responses with manageable ...
Even when promising clinical trials exist, and the FDA allows expanded access, rare disease patients like my granddaughter ...
The first study on deuterium-depleted water (DDW) concluded that a higher D/H ratio inside cells can trigger cell division.
Regenxbio said on Monday the U.S. Food and Drug Administration had declined to approve its gene therapy for a rare disease ...
Cell and gene therapies (CGTs) represent one of the most profound breakthroughs in modern medicine, offering the possibility ...
With a clutch of key data and planned regulatory applications this year from Avidity Biosciences, REGENXBIO and Capricor ...
The importance of reliable Case Management Services to deliver life-saving therapies to patients on time ...
DNA's iconic double helix does more than "just" store genetic information. Under certain conditions, it can temporarily fold ...
AskBio Inc., an RTP-based gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, has received U.S. Food and Drug Administration (FDA) acceptance of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results